Article info

Download PDFPDF

The role of biosimilars in the treatment of rheumatic diseases

Authors

  1. Correspondence to Professor Thomas Dörner, CC12 Department of Medicine, Rheumatology and Clinical Immunology, Charité—University Medicine Berlin, Chariteplatz 1, Berlin 10117, Germany;thomas.doerner{at}charite.de
View Full Text

Citation

Dörner T, Strand V, Castañeda-Hernández G, et al
The role of biosimilars in the treatment of rheumatic diseases

Publication history

  • Received September 21, 2012
  • Revised November 23, 2012
  • Accepted December 2, 2012
  • First published December 19, 2012.
Online issue publication 
February 05, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.